Literature DB >> 29272515

Update on colchicine, 2017.

Anastasia Slobodnick1,2, Binita Shah2,3, Svetlana Krasnokutsky1,2, Michael H Pillinger1,2.   

Abstract

Colchicine is an ancient medication that is currently approved for the treatment of gout and FMF. However, colchicine has a wide range of anti-inflammatory activities, and studies indicate that it may be beneficial in a variety of other conditions. This paper reviews the evidence for the well-established use of colchicine in gout, as well as several other rheumatic diseases. In addition, we highlight the potential benefit of colchicine in cardiac disease, including coronary artery disease in patients both with and without gout.
© The Author 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cardiovascular disease; colchicine; gout; inflammation

Mesh：

Substances：

Year:  2018        PMID： 29272515      PMCID： PMC5850858          DOI： 10.1093/rheumatology/kex453

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


  77 in total

1.  Colchicine and HMG Co-A reductase inhibitors induced myopathy-a case report.

Authors:  Josh Torgovnick; Nitin Sethi; Edward Arsura
Journal:  Neurotoxicology       Date:  2006-09-15       Impact factor: 4.294

2.  Letter: Colchicine in familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; J Gafni
Journal:  N Engl J Med       Date:  1976-01-15       Impact factor: 91.245

3.  Effect of steady-state atorvastatin on the pharmacokinetics of a single dose of colchicine in healthy adults under fasted conditions.

Authors:  Matthew W Davis; Suman Wason
Journal:  Clin Drug Investig       Date:  2014-04       Impact factor: 2.859

4.  Colchicine toxicity in patients with chronic renal failure.

Authors:  J J Montseny; A Meyrier; R K Gherardi
Journal:  Nephrol Dial Transplant       Date:  1996-10       Impact factor: 5.992

5.  Prevention of acute attacks of pseudogout with oral colchicine.

Authors:  T González; M Gantes
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

6.  2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Authors:  Dinesh Khanna; Puja P Khanna; John D Fitzgerald; Manjit K Singh; Sangmee Bae; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

7.  Tubulin bound to colchicine forms polymers different from microtubules.

Authors:  J M Andreu; S N Timasheff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Occupancy approach to colchicine dosage.

Authors:  S L Wallace; N H Ertel
Journal:  Lancet       Date:  1970-12-12       Impact factor: 79.321

9.  Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.

Authors:  Gregory C Borstad; Leslie R Bryant; Michael P Abel; Daren A Scroggie; Mark D Harris; Jeff A Alloway
Journal:  J Rheumatol       Date:  2004-12       Impact factor: 4.666

10.  EULAR recommendations for the management of familial Mediterranean fever.

Authors:  Seza Ozen; Erkan Demirkaya; Burak Erer; Avi Livneh; Eldad Ben-Chetrit; Gabriella Giancane; Huri Ozdogan; Illana Abu; Marco Gattorno; Philip N Hawkins; Sezin Yuce; Tilmann Kallinich; Yelda Bilginer; Daniel Kastner; Loreto Carmona
Journal:  Ann Rheum Dis       Date:  2016-01-22       Impact factor: 19.103
View more
  50 in total

1.  Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever.

Authors:  Rotem Tal; Rotem Semo Oz; Gil Amarilyo; Tal Eidlitz-Marcus; Ori Goldberg; Yoel Levinsky; Orit Peled; Liora Harel
Journal:  Rheumatol Int       Date:  2019-06-22       Impact factor: 2.631

Review 2.  Cardiac microtubules in health and heart disease.

Authors:  Matthew A Caporizzo; Christina Yingxian Chen; Benjamin L Prosser
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-09

3.  Colchicine in the treatment of refractory aphthous ulcerations: Review of the literature and two case reports.

Authors:  Mihaela Paula Toader; Irina Mihaela Esanu; Tatiana Taranu; Madalina Mocanu; Stefan Toader
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

Review 4.  Colchicine in Cardiovascular Disease: In-Depth Review.

Authors:  Spyridon G Deftereos; Frans J Beerkens; Binita Shah; George Giannopoulos; Dimitrios A Vrachatis; Sotiria G Giotaki; Gerasimos Siasos; Johny Nicolas; Clare Arnott; Sanjay Patel; Mark Parsons; Jean-Claude Tardif; Jason C Kovacic; George D Dangas
Journal:  Circulation       Date:  2021-12-29       Impact factor: 29.690

5.  Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis.

Authors:  Selçuk Şen; Eda Karahan; Cansu Büyükulaş; Yasin Onur Polat; Ali Yağız Üresin
Journal:  Anatol J Cardiol       Date:  2021-11       Impact factor: 1.596

Review 6.  Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus.

Authors:  Christopher B Oliveira; Mariana J Kaplan
Journal:  Semin Immunopathol       Date:  2022-03-30       Impact factor: 11.759

7.  Microtubules Increase Diastolic Stiffness in Failing Human Cardiomyocytes and Myocardium.

Authors:  Matthew A Caporizzo; Christina Yingxian Chen; Ken Bedi; Kenneth B Margulies; Benjamin L Prosser
Journal:  Circulation       Date:  2020-01-16       Impact factor: 29.690

8.  Colchicine and the heart.

Authors:  Massimo Imazio; Mark Nidorf
Journal:  Eur Heart J       Date:  2021-07-21       Impact factor: 29.983

9.  [Colchicine: old medication with new benefits : Use in rheumatology and beyond].

Authors:  Z Boyadzhieva; N Ruffer; M Krusche
Journal:  Z Rheumatol       Date:  2021-06-07       Impact factor: 1.372

Review 10.  The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.

Authors:  Monireh Golpour; Tahoora Mousavi; Mina Alimohammadi; Ali Mosayebian; Mohammadreza Shiran; Reza Alizadeh Navaei; Alireza Rafiei
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.